CD274 and colorectal cancer: To our knowledge, our study is (1) the largest to investigate the clinical response of anti–PD-1/PD-L1–targeting therapy in a population with refractory MSS colorectal cancer and (2) the first to investigate the association of liver metastases with response and PFS in a multivariable analysis that includes tumor genomics, TMB, and sidedness.